Our company news

Smooth Drug Development June 2024 News Release

Published on Friday July 05, 2024

We are working on the following new projects: Smooth started synopsis preparation services with Benzidamine+Cetylpyridinium chloride.

Read more →

Smooth Drug Development May 2024 News Release

Published on Wednesday June 05, 2024

We are working on the following new projects: A phase 3 clinical trial of Nimesulide Gel 2% was awarded to SDD.

Read more →

Smooth Drug Development April 2024 News Release

Published on Sunday May 05, 2024

We are working on the following new projects: Semaglutide trial was awarded to SDD.

Read more →

Smooth Drug Development March 2024 News Release

Published on Friday April 05, 2024

We are working on the following new projects: • We received a contract for a phase I study with Pembrolizumab.

Read more →

Smooth Drug Development February 2024 News Release

Published on Tuesday March 05, 2024

We are working on the following new projects: • A contract for a phase III study with Aflibercept was signed.

Read more →

Smooth Drug Development January 2024 News Release

Published on Monday February 05, 2024

January We are working on the following new projects: • We have successfully passed quality control of a global company and we are finalizing a contract for data management activities in observational programs.

Read more →

Smooth Drug Development December 2023 News Release

Published on Friday January 05, 2024

We are working on the following new projects: • We signed a contract for a phase III trial in patients with nasopharyngitis.

Read more →

Smooth Drug Development November 2023 News Release

Published on Wednesday December 06, 2023

We are working on the following new projects: • We won a bidding for an adalimumab trial, phase I.

Read more →

Smooth Drug Development October 2023 News Release

Published on Sunday November 05, 2023

October We are working on the following new projects: • We signed a contract for medical writing activities for a phase III trial with glucosamine + chondroitin sulfate.

Read more →

Smooth Drug Development September 2023 News Release

Published on Thursday October 05, 2023

We are working on the following new projects: • We signed a contract for medical writing activities for a BE trial with our long-term Client.

Read more →

Smooth Drug Development August 2023 News Release

Published on Tuesday September 05, 2023

August We are working on the following new projects: • We were awarded with medical writing activities for bioequivalence trials with Triptorelin.

Read more →

Smooth Drug Development July 2023 News Release

Published on Saturday August 05, 2023

We are working on the following new projects: • We were awarded with 6 bioequivalence trials with Gliclazide, Liraglutide, Vildagliptin, Dolutegravir and Empagliflozin 10 mg and 25 mg.

Read more →

Smooth Drug Development June 2023 News Release

Published on Wednesday July 05, 2023

We are working on the following new projects: • We signed a contract for a bioequivalence trial with Edoxaban.

Read more →

Smooth Drug Development May 2023 News Release

Published on Monday June 05, 2023

We are working on the following new projects: • We signed 2 contracts for bioequivalence trials with Rivaraxoban.

Read more →

Happy Clinical Trials Day!

Published on Saturday May 20, 2023

His report thus illustrates his awareness of the need to guard against selection bias and shows how he attempted to hold constant potential confounding factors - clinical condition, environment, and basic diet

Read more →